Aliskiren as Add-On Therapy in the Treatment of Hypertensive Diabetic Patients Inadequately Controlled with Valsartan/HCT Combination: A Placebo-Controlled Study

By Drummond W.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 5, 2011-10 ,pp. : 327-333

Adis International

Access to resources Recommend Favorite

Effect on the Atherogenic Marker Plasminogen Activator Inhibitor Type-1 of Addition of the ACE Inhibitor Imidapril to Angiotensin II Type 1 Receptor Antagonist Therapy in Hypertensive Patients with Abnormal Glucose Metabolism: A Prospective Cohort Study in Primary Care

By Yajima Ken   Shimada Akira  

Clinical Drug Investigation, Vol. 29, Iss. 12, 2009-12 ,pp. : 811-819

Adis International

Access to resources Recommend Favorite

Assessment of Heart Rate Variability after Calcium Antagonist and -Blocker Therapy in Patients with Essential Hypertension

By Rabbia F.   Martini G.   Sibona M.P.   Grosso T.   Simondi F.   Chiandussi L.   Veglio F.  

Clinical Drug Investigation, Vol. 17, Iss. 2, 1999-02 ,pp. : 111-118

Adis International

Access to resources Recommend Favorite

The costs of medical care for patients with severe chronic illness varies across the US, but quality of care is not necessarily related to cost of care

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 508, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Lercanidipine: glucose profile in diabetic hypertensive patients

By  

Inpharma, Vol. 1, Iss. 1354, 2002-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite